Jardiance® recommended for the treatment of adults with chronic kidney disease in the EU
Business Wire India The positive CHMP opinion is based on the landmark EMPA-KIDNEY trial, the largest and broadest dedicated SGLT2 inhibitor trial in chronic kidney disease (CKD) to date1,2,3 When…